Feature Channels: Vaccines

Filters close
Released: 2-Nov-2021 4:30 PM EDT
Study Observes Worse COVID-19 Vaccine Response in Patients Taking Glucocorticoids or B-Cell Therapies
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that people with chronic inflammatory diseases, such as rheumatoid arthritis (RA), who take immunosuppressive therapy appear to have an impaired immunity response to SARS-CoV-2, the coronavirus that causes COVID-19, vaccines. Patients currently on glucocorticoids or B-cell depleting therapy appear to have an even more severely impeded vaccine response.

Newswise: Unexpected Antibody Type Found in People with Malaria Infections
Released: 2-Nov-2021 3:55 PM EDT
Unexpected Antibody Type Found in People with Malaria Infections
University of Maryland School of Medicine

In a newly published study, researchers at the University of Maryland School of Medicine have detected antibodies primarily made in response to infections in the mucous membranes — in such areas as the lungs, intestines, or vagina — in study participants with malaria.

Released: 2-Nov-2021 1:20 PM EDT
Fear of Side Effects, Including Rheumatic Disease Flares, Driving COVID-19 Vaccine Hesitancy Among Some Patients
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that in Alabama, one in 10 racial or ethnic minority patients with a rheumatic disease in a large rheumatology clinic said they were unlikely to get vaccinated against COVID-19.

   
Released: 2-Nov-2021 12:05 PM EDT
Morgridge invites experts to discuss COVID-19 vaccines for kids in upcoming speaker series
Morgridge Institute for Research

The Morgridge Institute for Research will broadcast a free webinar on November 9, featuring a conversation with experts on the front lines of pediatric vaccine development and public health.

   
Newswise: Engineering Next-Gen Vaccines
Released: 2-Nov-2021 11:35 AM EDT
Engineering Next-Gen Vaccines
University of Delaware

The University of Delaware's Aditya Kunjapur has been awarded the 2021 American Institute of Chemical Engineers (AIChE) Langer Prize for Innovation and Entrepreneurial Excellence, a highly competitive award that comes with a stipend to pursue “blue sky” ideas.

Released: 2-Nov-2021 11:10 AM EDT
COVID-19 Vaccine Gets Strong Response in Some With Weak Immunity
Cedars-Sinai

Researchers at Cedars-Sinai found that patients with inflammatory bowel disease (IBD)─whose treatment can weaken the immune system─produced a strong antibody response to COVID-19 vaccination. The study findings have been published in the Annals of Internal Medicine.

Newswise:Video Embedded together-by-st-jude-teaches-children-about-the-covid-19-vaccines-in-new-coloring-book
VIDEO
Released: 2-Nov-2021 10:00 AM EDT
Together by St. Jude Teaches Children about the COVID-19 Vaccines in New Coloring Book
St. Jude Children's Research Hospital

Following FDA authorization of the COVID-19 vaccine for 5- to 11-year-olds, Together by St. Jude releases a free coloring book that educates children on COVID-19 vaccines.

   
Released: 1-Nov-2021 4:55 PM EDT
Patients taking Rituximab Could Benefit from Third COVID-19 Vaccine Dose
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows patients using rituximab were able to produce antibodies against COVID-19 after receiving a third vaccine dose, even if there was no development of the antibody after the first two.

Released: 1-Nov-2021 4:55 PM EDT
Nearly One Third of Lupus Patients in One Study Had Low Responses to COVID-19 Vaccines
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that nearly 30% of patients with lupus in a multi-ethnic and multi-racial study had a low response to the new COVID-19 vaccines.

Released: 1-Nov-2021 3:20 PM EDT
Study Finds COVID-19 Vaccine Not Associated with Severe Disease Flare in Patients with Rheumatic Diseases
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that the COVID-19 vaccine was not associated with severe disease flares in patients with rheumatic diseases.

Released: 1-Nov-2021 2:00 PM EDT
In Covid-19 Vaccinated People, Those with Prior Infection Likely to Have More Antibodies
Johns Hopkins Medicine

In what is believed to be one of the largest studies of its kind, Johns Hopkins Medicine researchers have shown that antibody levels against SARS-CoV-2 (the COVID-19 virus) stay more durable — that is, remain higher over an extended period of time — in people who were infected by the virus and then received protection from two doses of messenger RNA (mRNA) vaccine compared with those who only got immunized.

31-Oct-2021 10:00 AM EDT
NYU Langone Presentations at American College of Rheumatology Convergence 2021 to Address Vaccine Efficacy and High-risk Pregnancy
NYU Langone Health

NYU Langone rheumatologists are presenting their discoveries at the annual American College of Rheumatology conference, November 1 to November 9. The conference will be held virtually.

Released: 29-Oct-2021 1:25 PM EDT
Chatbot for addressing COVID-19 vaccine hesitancy
CNRS (Centre National de Recherche Scientifique / National Center of Scientific Research)

What if a few minutes of interaction with a chatbot could effectively address vaccine concerns?

   
Newswise: Why I'll Vaccinate My Kids
Released: 29-Oct-2021 11:25 AM EDT
Why I'll Vaccinate My Kids
Rutgers University-New Brunswick

As the Food and Drug Administration edges closer to emergency use approval of the Pfizer COVID-19 vaccine for children ages 5-11 – which could become available as soon as early November – Rutgers faculty and staff share reasons for why they'll vaccinate their children.

     
Released: 29-Oct-2021 4:05 AM EDT
For people of color in L.A., misinformation, past injustices contribute to vaccine hesitancy
University of California, Los Angeles (UCLA), Health Sciences

New UCLA research finds that misinformation and politicization, awareness of past injustices involving medical research, and fears about the inequitable distribution of vaccines all contributed to hesitancy to be vaccinated among Los Angeles' People of Color.

Released: 27-Oct-2021 10:40 AM EDT
More than 75% of Texans have COVID-19 antibodies, one of the world’s largest assessments finds
University of Texas Health Science Center at Houston

A year after launching one of the world’s largest COVID-19 antibody surveys, Texas CARES, public health experts at The University of Texas Health Science Center at Houston (UTHealth Houston) and the Texas Department of State Health Services (DSHS) are estimating that over 75% of Texans have COVID-19 antibodies.

Newswise: Long-term immune response to Sputnik-V COVID vaccine
Released: 27-Oct-2021 8:40 AM EDT
Long-term immune response to Sputnik-V COVID vaccine
Kazan Federal University

The contributors are Kazan Federal University, Kazan State Medical Academy, Thapar Institute of Engineering and Technology, and the University of Liverpool.

Newswise: Studies reveal what makes the Delta variant so infectious
Released: 26-Oct-2021 4:45 PM EDT
Studies reveal what makes the Delta variant so infectious
Boston Children's Hospital

The Delta variant of SARS-CoV-2 has swept the globe, becoming the dominant variant within just a few months.

Released: 26-Oct-2021 4:35 PM EDT
Study supports safety of COVID-19 vaccines in people with a history of severe allergic reactions
Massachusetts General Hospital

New research addresses ongoing concerns regarding risks of allergic reactions after receiving mRNA COVID-19 vaccines, particularly for individuals with a history of severe allergic reactions.

Released: 26-Oct-2021 8:55 AM EDT
COVID-19: Does having received the BCG vaccine as a child provide a protective effect?
Institut National de la Recherche Scientifique (INRS)

Being vaccinated during childhood with the BCG (Bacille Calmette-Guérin) vaccine against tuberculosis is not a long-term protective factor against COVID-19, despite what was thought at the beginning of the pandemic.

Released: 26-Oct-2021 8:45 AM EDT
Cleveland Clinic Launches First-of-its Kind Preventive Breast Cancer Vaccine Study
Cleveland Clinic

Cleveland Clinic researchers have opened a novel study for a vaccine aimed at eventually preventing triple-negative breast cancer, the most aggressive and lethal form of the disease.

Released: 25-Oct-2021 12:35 PM EDT
Loyola Medicine Prepares for Possible Approval of the COVID-19 Vaccine for Children
Loyola Medicine

The Food and Drug Administration (FDA) is set to meet on October 26 to discuss the Emergency Use Authorization (EUA) of the Pfizer-BioNTech COVID-19 vaccine for children aged five to 11. Ahead of this meeting, Loyola Medicine is taking steps to ensure the health system is prepared to administer Pfizer vaccines to children if approval is granted.

Released: 25-Oct-2021 11:50 AM EDT
March Madness: Researcher sees temporary increase in COVID-19 cases in counties where universities played in NCAA Tournament   
Beth Israel Lahey Health

A new analysis by a researcher at Beth Israel Deaconess Medical Center (BIDMC) finds a link between large gatherings of unvaccinated county residents – both students and non-students – and an increase in COVID-19 infections in the university’s community.

Newswise: Dr. Dylan Roby, UCI visiting professor of health, society and behavior, is available to comment on vaccine mandates, healthcare policy and reform.
Released: 22-Oct-2021 4:45 PM EDT
Dr. Dylan Roby, UCI visiting professor of health, society and behavior, is available to comment on vaccine mandates, healthcare policy and reform.
University of California, Irvine

Lithium is a common medication prescribed to patients with psychiatric disorders, namely bipolar disorder, schizophrenia, and depression. It is used as a mood stabilizer and lessens the intensity of manic episodes, with particular benefit in reducing suicidality. While highly effective, the drug requires routine blood monitoring, which can be uncomfortable, expensive, and inconvenient for patients who must travel to clinical labs for frequent blood testing.

   
Released: 22-Oct-2021 4:25 PM EDT
COVID vaccine booster increases antibody responses, is protective in rhesus macaques
NIH, National Institute of Allergy and Infectious Diseases (NIAID)

A booster dose of the mRNA-1273 COVID-19 vaccine given to rhesus macaques about six months after their primary vaccine series significantly increased levels of neutralizing antibodies against all known SARS-CoV-2 variants of concern, according to a new study from National Institutes of Health scientists and colleagues.

Released: 22-Oct-2021 11:40 AM EDT
Shape of virus may determine RSV infection outcomes
Washington University in St. Louis

Using a novel technology, the lab of Michael Vahey at the McKelvey School of Engineering uncovered shape-shifting properties of a common respiratory virus.

Released: 21-Oct-2021 6:50 PM EDT
Vaccines offer strong protection against death from Delta, study says
University of Edinburgh

Vaccination is over 90 per cent effective at preventing deaths from the Delta variant of Covid-19, according to the first country-level data on mortality.

Released: 21-Oct-2021 1:00 PM EDT
Duke Researchers Receive Grant to Roll Out Next-Generation Coronavirus Vaccine
Duke Health

The National Institute of Allergy and Infectious Diseases (NIAID) has awarded $17.5 million over three years to the Duke Human Vaccine Institute to develop a vaccine that protects against multiple types of coronaviruses and viral variants.

Newswise: LLNL joins Human Vaccines Project to accelerate vaccine development and understanding of immune response
Released: 21-Oct-2021 8:40 AM EDT
LLNL joins Human Vaccines Project to accelerate vaccine development and understanding of immune response
Lawrence Livermore National Laboratory

Lawrence Livermore National Laboratory has joined the international Human Vaccines Project, bringing Lab expertise and computing resources to the consortium to aid development of a universal coronavirus vaccine and improve understanding of immune response.

Released: 20-Oct-2021 4:55 PM EDT
In pregnant women with COVID-19, sex of fetus may influence maternal and placental immune response and neonatal immune protection
Massachusetts General Hospital

In pregnant women who tested positive for SARS-CoV-2, the virus that causes COVID-19, male placentas demonstrated significantly higher levels of certain genes and proteins associated with increased immune activation compared with female placentas, according to a new study published in Science Translational Medicine.

Newswise:Video Embedded bbq-lighter-combined-with-microneedles-sparks-breakthrough-in-covid-19-vaccine-delivery
VIDEO
Released: 20-Oct-2021 4:50 PM EDT
BBQ Lighter, Combined With Microneedles, Sparks Breakthrough in Covid-19 Vaccine Delivery
Georgia Institute of Technology

Future vaccine delivery may rely on everyday items like BBQ lighters and microneedles, thanks to the ingenuity of a team of Georgia Institute of Technology and Emory University researchers.

Newswise: Marketing strategies can help overcome COVID-19 vaccine hesitancy, study shows
Released: 19-Oct-2021 4:40 PM EDT
Marketing strategies can help overcome COVID-19 vaccine hesitancy, study shows
University of Notre Dame

New research from the University of Notre Dame suggests that experts from varying fields need to work together to overcome the public health crisis and that science can benefit by using marketing strategies with vaccine holdouts, much like brands do with customers.

   
Released: 19-Oct-2021 4:35 PM EDT
New study demonstrates community engagement efforts are critical to ensuring the equitable inclusion of BIPOC communities in vaccine clinical trials
Covid-19 Prevention Network (CoVPN)

A team of research experts from the COVID-19 Prevention Network (CoVPN), headquartered at Fred Hutchinson Cancer Research Center, has demonstrated that through robust community engagement, equitable inclusion in vaccine clinical trials can make a powerful impact in the health of underrepresented communities.

15-Oct-2021 2:10 PM EDT
COVID-19 Vaccination Strategies: When Is One Dose Better Than Two?
American Institute of Physics (AIP)

While most of the COVID-19 vaccines are designed as a two-dose regimen, some countries have prioritized vaccinating as many people as possible with a single dose before giving out an additional dose. In the journal Chaos, researchers illustrate the conditions under which a "prime first" vaccine campaign is most effective at stopping the spread of the COVID-19 virus. The team found the vaccine waning rate to be a critically important factor in the decision.

   
18-Oct-2021 11:15 AM EDT
Targeted Interventions To Contain Pandemics, Minimize Societal Disruption
American Institute of Physics (AIP)

Nonpharmaceutical interventions, such as isolation, quarantines, and lockdowns, have been implemented in an effort to contain the pandemic, but these are often disruptive and costly. In Chaos, researchers identify new and sustainable interventions to contain outbreaks while minimizing the economic and social costs. They built a data-driven mobility model to simulate COVID-19 spreading in Hong Kong, by combining synthetic population, human behavior patterns, and a viral transmission model, and found that by controlling a small percentage of grids, the virus could be largely contained.

   
Newswise: Critical Care and Pulmonary Societies Encourage Flu Shots Amid COVID-19 Spread
Released: 19-Oct-2021 10:20 AM EDT
Critical Care and Pulmonary Societies Encourage Flu Shots Amid COVID-19 Spread
American Thoracic Society (ATS)

The members of the Critical Care Societies Collaborative, which includes the American Association of Critical-Care Nurses, American College of Chest Physicians, American Thoracic Society, and Society of Critical Care Medicine, strongly urge individuals to get vaccinated against the COVID-19 virus and to receive their influenza (flu) immunizations for the upcoming flu season.

Released: 18-Oct-2021 6:20 PM EDT
High effectiveness of mix-and-match COVID-19 vaccines
Umea University

People who had received a first dose of the Oxford-AstraZeneca COVID-19 vaccine and received an mRNA vaccine for their second dose had a lower risk of infection compared to people who had received both doses of the Oxford-AstraZeneca vaccine.

Released: 18-Oct-2021 4:15 PM EDT
Cancer Patients With Poor Antibody Response to COVID-19 Vaccines Also Lack Secondary Immune Response, Study Shows
Mount Sinai Health System

Patients with the blood cancer multiple myeloma often mount a poor antibody response to COVID-19 vaccines. Mount Sinai researchers have now discovered that these patients also have a weak response from a different part of the immune system, known as T cells. Their discovery was published in a research letter in Cancer Cell in October.

Released: 18-Oct-2021 10:40 AM EDT
Will There Be a Twindemic?
Global Virus Network

“Twindemic” is a term that has not yet been in the headlines but is likely to become part of our lexicon as the summer progresses.

Released: 18-Oct-2021 8:30 AM EDT
Even College Campuses with 100 Percent Vaccine Rates Need COVID-19 Tests
Florida Atlantic University

An analytical study examined levels of vaccine efficacy and mitigation strategies. If 100 percent were vaccinated with 90 percent vaccine efficacy, testing and quarantine did not substantially reduce infections. At 75 percent efficacy, weekly testing substantially reduced the number of infections; at 50 percent, testing and quarantine markedly reduced infections. At 50 to 75 percent efficacy, testing reduced infections up to 93.6 percent. Quarantining for 10 days only modestly reduced infections until vaccine efficacy dropped to 50 percent. Findings suggest that testing and isolating positive cases may remain important mitigation strategies for universities even with 100 percent of students vaccinated.

15-Oct-2021 8:30 AM EDT
Eight months later: Researchers compare immune responses elicited by three COVID-19 vaccines
Beth Israel Deaconess Medical Center

In a paper published in the New England Journal of Medicine, a team of experts at Beth Israel Deaconess Medical Center compared immune responses induced by the three COVID-19 vaccines over an eight-month follow-up period.

Released: 15-Oct-2021 8:30 AM EDT
Flu and Heart Disease: The Surprising Connection That Should Convince You to Schedule Your Shot
Houston Methodist

Patients who have cardiovascular disease are at increased risk of serious complications from the flu, according to a new study by Houston Methodist physician researchers published in the Journal of the American Heart Association. The study found that not only are traditional flu-related outcomes worse among some patients with CVD, but infection in those patients also is associated with an increased risk of cardiovascular events and both CV-related mortality and mortality from all causes.



close
1.72482